Telemedicine and lower-barrier access to buprenorphine hold potential to make gains against the opioid epidemic after the COVID-19 crisis subsides.
Isolation and barriers to harm reduction services could increase overdoses and new HIV infections among people who use drugs, experts worry.
Federally qualified health centers see 10 times the HCV prevalence of the general population, but aren't yet reaching their full potential in fighting this consequence of the opioid epidemic.
New research shows that the majority of patients don’t receive any further treatment in the month after a detox episode — but those who do are much more likely to survive.
A pharmacy-led campaign to boost vaccinations highlight the important role of pharmacists and the ED in public health emergencies.